@article{01HV5YG0KNY7MHSPTN1VGF8ZAB,
  abstract     = {{Objectives Cytogenetic abnormalities are predictors of poor prognosis in multiple myeloma (MM). This paper aims to build and validate a multiparametric conventional and functional whole-body MRI-based prediction model for cytogenetic risk classification in newly diagnosed MM.Methods Patients with newly diagnosed MM who underwent multiparametric conventional whole-body MRI, spinal dynamic contrast-enhanced (DCE-)MRI, spinal diffusion-weighted MRI (DWI) and had genetic analysis were retrospectively included (2011-2020/Ghent University Hospital/Belgium). Patients were stratified into standard versus intermediate/high cytogenetic risk groups. After segmentation, 303 MRI features were extracted. Univariate and model-based methods were evaluated for feature and model selection. Testing was performed using receiver operating characteristic (ROC) and precision-recall curves. Models comparing the performance for genetic risk classification of the entire MRI protocol and of all MRI sequences separately were evaluated, including all features. Four final models, including only the top three most predictive features, were evaluated.Results Thirty-one patients were enrolled (mean age 66 +/- 7 years, 15 men, 13 intermediate-/high-risk genetics). None of the univariate models and none of the models with all features included achieved good performance. The best performing model with only the three most predictive features and including all MRI sequences reached a ROC-area-under-the-curve of 0.80 and precision-recall-area-under-the-curve of 0.79. The highest statistical performance was reached when all three MRI sequences were combined (conventional whole-body MRI + DCE-MRI + DWI). Conventional MRI always outperformed the other sequences. DCE-MRI always outperformed DWI, except for specificity.Conclusions A multiparametric MRI-based model has a better performance in the noninvasive prediction of high-risk cytogenetics in newly diagnosed MM than conventional MRI alone.Critical relevance statement An elaborate multiparametric MRI-based model performs better than conventional MRI alone for the noninvasive prediction of high-risk cytogenetics in newly diagnosed multiple myeloma; this opens opportunities to assess genetic heterogeneity thus overcoming sampling bias.Key points center dot Standard genetic techniques in multiple myeloma patients suffer from sampling bias due to tumoral heterogeneity. center dot Multiparametric MRI noninvasively predicts genetic risk in multiple myeloma. center dot Combined conventional anatomical MRI, DCE-MRI, and DWI had the highest statistical performance to predict genetic risk. center dot Conventional MRI alone always outperformed DCE-MRI and DWI separately to predict genetic risk. DCE-MRI alone always outperformed DWI separately, except for the parameter specificity to predict genetic risk. center dot This multiparametric MRI-based genetic risk prediction model opens opportunities to noninvasively assess genetic heterogeneity thereby overcoming sampling bias in predicting genetic risk in multiple myeloma.Key points center dot Standard genetic techniques in multiple myeloma patients suffer from sampling bias due to tumoral heterogeneity. center dot Multiparametric MRI noninvasively predicts genetic risk in multiple myeloma. center dot Combined conventional anatomical MRI, DCE-MRI, and DWI had the highest statistical performance to predict genetic risk. center dot Conventional MRI alone always outperformed DCE-MRI and DWI separately to predict genetic risk.

DCE-MRI alone always outperformed DWI separately, except for the parameter specificity to predict genetic risk. center dot This multiparametric MRI-based genetic risk prediction model opens opportunities to noninvasively assess genetic heterogeneity thereby overcoming sampling bias in predicting genetic risk in multiple myeloma.Key points center dot Standard genetic techniques in multiple myeloma patients suffer from sampling bias due to tumoral heterogeneity. center dot Multiparametric MRI noninvasively predicts genetic risk in multiple myeloma. center dot Combined conventional anatomical MRI, DCE-MRI, and DWI had the highest statistical performance to predict genetic risk. center dot Conventional MRI alone always outperformed DCE-MRI and DWI separately to predict genetic risk. DCE-MRI alone always outperformed DWI separately, except for the parameter specificity to predict genetic risk. center dot This multiparametric MRI-based genetic risk prediction model opens opportunities to noninvasively assess genetic heterogeneity thereby overcoming sampling bias in predicting genetic risk in multiple myeloma.Key points center dot Standard genetic techniques in multiple myeloma patients suffer from sampling bias due to tumoral heterogeneity. center dot Multiparametric MRI noninvasively predicts genetic risk in multiple myeloma. center dot Combined conventional anatomical MRI, DCE-MRI, and DWI had the highest statistical performance to predict genetic risk. center dot Conventional MRI alone always outperformed DCE-MRI and DWI separately to predict genetic risk. DCE-MRI alone always outperformed DWI separately, except for the parameter specificity to predict genetic risk. center dot This multiparametric MRI-based genetic risk prediction model opens opportunities to noninvasively assess genetic heterogeneity thereby overcoming sampling bias in predicting genetic risk in multiple myeloma.Key points center dot Standard genetic techniques in multiple myeloma patients suffer from sampling bias due to tumoral heterogeneity. center dot Multiparametric MRI noninvasively predicts genetic risk in multiple myeloma. center dot Combined conventional anatomical MRI, DCE-MRI, and DWI had the highest statistical performance to predict genetic risk. center dot Conventional MRI alone always outperformed DCE-MRI and DWI separately to predict genetic risk. DCE-MRI alone always outperformed DWI separately, except for the parameter specificity to predict genetic risk. center dot This multiparametric MRI-based genetic risk prediction model opens opportunities to noninvasively assess genetic heterogeneity thereby overcoming sampling bias in predicting genetic risk in multiple myeloma.}},
  articleno    = {{106}},
  author       = {{Van Den Berghe, Thomas and Verberckmoes, Bert and Kint, Nicolas and Wallaert, Steven and De Vos, Nicolas and Algoet, Chloé and Behaeghe, Maxim and Dutoit, Julie and Van Roy, Nadine and Vlummens, Philip and Dendooven, Amélie and Van Dorpe, Jo and Offner, Fritz and Verstraete, Koenraad}},
  issn         = {{1869-4101}},
  journal      = {{INSIGHTS INTO IMAGING}},
  keywords     = {{Radiology, Nuclear Medicine and imaging,Multiple myeloma,Multiparametric magnetic resonance imaging,Magnetic resonance imaging,Genetics,Diffusion magnetic resonance imaging}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{19}},
  title        = {{Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging}},
  url          = {{http://doi.org/10.1186/s13244-024-01672-1}},
  volume       = {{15}},
  year         = {{2024}},
}

Altmetric

View in Altmetric

Web of Science

Times cited: